2型糖尿病患者自我报告的低血糖风险预测模型的开发和验证:一项纵向队列研究
Hongmei Xu1, Hangqing Yu2, Zhengnan Cheng3
1NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.
Journal of diabetes investigation
|January 20, 2024
概括
这项研究创建了简单的预测模型,以识别患有低血糖风险的2型糖尿病患者. 这些模型具有很好的准确性,可以帮助临床决策,以更好地帮助患者自我护理和预防.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病研究研究 糖尿病研究
- 临床预测建模临床预测建模
背景情况:
- 低血糖是2型糖尿病管理中的重要并发症.
- 有效的风险预测对于预防不良事件和改善患者结果至关重要.
研究的目的:
- 开发和验证2型糖尿病患者低血糖风险的简单预测模型.
- 评估3个月和6个月后开发的模型的预测性能.
主要方法:
- 在第三级医院对1,303名2型糖尿病患者进行前性分析.
- 开发3个月和6个月低血糖风险预测模型.
- 使用ROC曲线,尤登指数,灵敏度和特异性的模型性能评估.
主要成果:
- 低血糖发生在28.4% (3个月) 和37.2% (6个月) 的患者中.
- 关键预测因素包括年龄,中心肥胖,密集胰岛素治疗,先前低血糖频率和教育.
- 模型显示出良好的区分 (AUC 0.711-0.723) 和校准,具有明显的临床净益.
结论:
- 验证了2型糖尿病的3个月和6个月低血糖风险预测模型.
- 这些模型表现出良好的区分和校准,支持临床决策.
- 这些工具可以引导患者改善自我护理和降血糖预防策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263
Diabetes: Symptoms, Diagnosis, and Complications
546
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
546
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Pathophysiology of Diabetes
940
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
940
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285


